---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-031476"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T04:03:14.574082+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# MoonLake posts Capital Markets Day presentation; no specific data disclosed in filing text

## Summary
- Company filed a Form 8-K announcing the posting of an investor presentation for Capital Markets Day on June 7, 2022.
- Presentation covers clinical development program and recent developments, but no concrete figures or updates are provided in the excerpt.
- Full presentation is available on the company's IR website; no financial or pipeline details are included in the 8-K text.
- This filing is procedural under Regulation FD; material content requires review of the actual presentation slides.

## SEC filing metadata
- accession: 0001213900-22-031476
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390022031476/0001213900-22-031476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390022031476/ea161246-8k_moonlake.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-031476
- JSON: https://secwatch.observer/filing/0001213900-22-031476.json
- Plain text: https://secwatch.observer/filing/0001213900-22-031476.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.